Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
$0.60
+3.3%
$0.69
$0.53
$2.21
$5.45M1.91716,867 shs31,226 shs
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
$0.60
+3.3%
$0.69
$0.53
$2.21
$5.45M1.91716,867 shs31,226 shs
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
$0.45
+35.4%
$0.33
$0.22
$2.54
$25.11M0.882.84 million shs14.39 million shs
Comstock Inc. stock logo
LODE
Comstock
$3.74
-1.8%
$3.15
$1.26
$10.10
$121.56M1.57622,730 shs130,566 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
0.00%+0.17%-15.55%-1.67%+59,999,900.00%
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
0.00%+0.17%-15.55%-1.67%+59,999,900.00%
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
0.00%+51.33%+56.50%+28.18%-74.35%
Comstock Inc. stock logo
LODE
Comstock
0.00%-3.11%+16.88%+97.88%+133.90%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
2.3561 of 5 stars
3.55.00.00.00.60.00.6
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
2.3561 of 5 stars
3.55.00.00.00.60.00.6
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
2.7894 of 5 stars
3.53.00.00.02.31.70.6
Comstock Inc. stock logo
LODE
Comstock
1.5082 of 5 stars
3.00.00.00.02.70.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
3.00
Buy$5.00733.33% Upside
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
3.00
Buy$5.00733.33% Upside
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
3.00
Buy$2.83524.08% Upside
Comstock Inc. stock logo
LODE
Comstock
2.00
Hold$26.00595.19% Upside

Current Analyst Ratings Breakdown

Latest LODE, CGTX, ASNS, and ASNS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/26/2025
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$3.00
5/27/2025
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$5.00 ➝ $3.00
5/8/2025
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$8.00 ➝ $4.00
(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
$7.76M0.71N/AN/A$0.36 per share1.67
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
$7.76M0.71N/AN/A$0.36 per share1.67
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
N/AN/AN/AN/A$0.31 per shareN/A
Comstock Inc. stock logo
LODE
Comstock
$3.38M35.91N/AN/A$0.68 per share5.50
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
-$4.37M-$0.56N/AN/AN/A-53.20%-181.28%-50.88%8/13/2025 (Estimated)
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
-$4.37M-$0.56N/AN/AN/A-53.20%-181.28%-50.88%8/13/2025 (Estimated)
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
-$33.97M-$0.74N/AN/AN/AN/A-194.42%-115.14%8/6/2025 (Estimated)
Comstock Inc. stock logo
LODE
Comstock
$9.16M-$1.20N/AN/AN/A-1,210.13%-33.56%-23.62%N/A

Latest LODE, CGTX, ASNS, and ASNS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2025Q1 2025
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
-$0.25-$0.22+$0.03-$0.22$1.20 million$0.72 million
5/13/2025Q1 2025
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
-$0.25-$0.22+$0.03-$0.22$1.20 million$0.72 million
5/6/2025Q1 2025
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
-$0.12-$0.14-$0.02-$0.14N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
N/AN/AN/AN/AN/A
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
N/AN/AN/AN/AN/A
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
N/AN/AN/AN/AN/A
Comstock Inc. stock logo
LODE
Comstock
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
0.06
1.56
0.89
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
0.06
1.56
0.89
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
N/A
2.09
2.09
Comstock Inc. stock logo
LODE
Comstock
0.16
2.45
2.45

Institutional Ownership

CompanyInstitutional Ownership
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
12.43%
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
12.43%
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
43.35%
Comstock Inc. stock logo
LODE
Comstock
7.96%

Insider Ownership

CompanyInsider Ownership
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
2.90%
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
2.90%
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
14.40%
Comstock Inc. stock logo
LODE
Comstock
4.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
409.21 million8.95 millionN/A
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
409.21 million8.95 millionN/A
Cognition Therapeutics, Inc. stock logo
CGTX
Cognition Therapeutics
2061.99 million53.07 millionNot Optionable
Comstock Inc. stock logo
LODE
Comstock
3032.42 million215.10 millionOptionable

Recent News About These Companies

Comstock Set to Join Russell Microcap® Index

New MarketBeat Followers Over Time

Media Sentiment Over Time

Actelis Networks stock logo

Actelis Networks NASDAQ:ASNS

$0.60 +0.02 (+3.34%)
Closing price 07/3/2025 02:14 PM Eastern
Extended Trading
$0.58 -0.02 (-3.33%)
As of 07/3/2025 04:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Actelis Networks, Inc. engages in the design, development, manufacture, and marketing of cyber hardened, hybrid fiber, networking solutions for Internet of Things and telecommunication companies in North America, Europe, the Middle East, Israel, and the Asia Pacific. It provides rapid-deployment networking solutions for wide-area IoT applications, including federal, state, and local governments; intelligent traffic systems; and military, utility, rail, telecom, and campus applications. The company's products include ethernet access devices; network aggregator switches; and Advanced MetaLIGHT/ Gigaline element management systems software, which enables remote management, monitoring, maintenance, and configuration of the installed equipment in the network. It also offers dynamic spectral software; and access broadband equipment. It serves offers its products through system integrators, distributors, contractors, resellers, and consultants. The company was incorporated in 1998 and is headquartered in Fremont, California.

Actelis Networks stock logo

Actelis Networks NASDAQ:ASNS

$0.60 +0.02 (+3.34%)
Closing price 07/3/2025 02:14 PM Eastern
Extended Trading
$0.58 -0.02 (-3.33%)
As of 07/3/2025 04:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Actelis Networks, Inc. engages in the design, development, manufacture, and marketing of cyber hardened, hybrid fiber, networking solutions for Internet of Things and telecommunication companies in North America, Europe, the Middle East, Israel, and the Asia Pacific. It provides rapid-deployment networking solutions for wide-area IoT applications, including federal, state, and local governments; intelligent traffic systems; and military, utility, rail, telecom, and campus applications. The company's products include ethernet access devices; network aggregator switches; and Advanced MetaLIGHT/ Gigaline element management systems software, which enables remote management, monitoring, maintenance, and configuration of the installed equipment in the network. It also offers dynamic spectral software; and access broadband equipment. It serves offers its products through system integrators, distributors, contractors, resellers, and consultants. The company was incorporated in 1998 and is headquartered in Fremont, California.

Cognition Therapeutics stock logo

Cognition Therapeutics NASDAQ:CGTX

$0.45 +0.12 (+35.44%)
Closing price 07/3/2025 03:58 PM Eastern
Extended Trading
$0.45 0.00 (-0.44%)
As of 07/3/2025 05:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer's disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. The company was incorporated in 2007 and is headquartered in Purchase, New York.

Comstock stock logo

Comstock NYSE:LODE

$3.74 -0.07 (-1.84%)
Closing price 07/3/2025 03:57 PM Eastern
Extended Trading
$3.74 0.00 (0.00%)
As of 07/3/2025 04:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Comstock Inc. engages in the systemic decarbonization business in Nevada and internationally. It operates through Renewable Energy, Mining, and Strategic and Other Investments segments. It will develop technology for the deploying of extraction and refining facilities that convert wasted and unused biomass and other natural resources; and a demonstration system to extract black mass containing lithium, graphite, nickel, cobalt, manganese, copper, aluminum, and other metals from up to lithium-ion batteries. The company also owns the Lucerne Project located in the Storey County, Nevada; and the Spring Valley Project situated in the Lyon County, Nevada. In addition, it offers upstream and downstream design, engineering, fabrication, procurement, and construction solutions; and invests in non-mining real estate investments. The company was incorporated in 2008 and is based in Virginia City, Nevada.